Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


17.12.2018

1 Biochemistry (Mosc)
1 Int J Neurosci
5 Mov Disord
1 Nat Rev Neurol
1 Nature
1 Neurology
1 Neurosci Lett
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biochemistry (Mosc)

  1. ALISEYCHIK MP, Andreeva TV, Rogaev EI
    Immunogenetic Factors of Neurodegenerative Diseases: The Role of HLA Class II.
    Biochemistry (Mosc). 2018;83:1104-1116.
    PubMed     Text format     Abstract available


    Int J Neurosci

  2. WU W, Han Y, Fan X, Qinghu L, et al
    Protective mechanism of Wnt4 gene on Parkinson's disease (PD) transgenic Drosophila (1).
    Int J Neurosci. 2018 Dec 11:1-25. doi: 10.1080/00207454.2018.1557168.
    PubMed     Text format     Abstract available


    Mov Disord

  3. ASSAF F, Schiller Y
    A chemogenetic approach for treating experimental Parkinson's disease.
    Mov Disord. 2018 Dec 10. doi: 10.1002/mds.27554.
    PubMed     Text format     Abstract available

  4. CHUNG SJ, Jeon S, Yoo HS, Yoon JH, et al
    Gastrectomy and nigrostriatal dopaminergic depletion in de novo Parkinson's disease.
    Mov Disord. 2018 Dec 10. doi: 10.1002/mds.27580.
    PubMed     Text format    

  5. TRINH J, Lohmann K, Baumann H, Balck A, et al
    Utility and implications of exome sequencing in early-onset Parkinson's disease.
    Mov Disord. 2018 Dec 10. doi: 10.1002/mds.27559.
    PubMed     Text format     Abstract available

  6. BEJR-KASEM H, Pagonabarraga J, Martinez-Horta S, Sampedro F, et al
    Disruption of the default mode network and its intrinsic functional connectivity underlies minor hallucinations in Parkinson's disease.
    Mov Disord. 2018 Dec 10. doi: 10.1002/mds.27557.
    PubMed     Text format     Abstract available

  7. GARGOURI F, Gallea C, Mongin M, Pyatigorskaya N, et al
    Multimodal magnetic resonance imaging investigation of basal forebrain damage and cognitive deficits in Parkinson's disease.
    Mov Disord. 2018 Dec 10. doi: 10.1002/mds.27561.
    PubMed     Text format     Abstract available


    Nat Rev Neurol

  8. RIDLER C
    Parkinson disease gene therapy rewires brain circuits to improve motor function.
    Nat Rev Neurol. 2018 Dec 12. pii: 10.1038/s41582-018-0120.
    PubMed     Text format    


    Nature

  9. STOLZ A, Dikic I
    Elusive mitochondrial connection to inflammation uncovered.
    Nature. 2018;561:185-186.
    PubMed     Text format    


    Neurology

  10. PRANGE S, Danaila T, Laurencin C, Caire C, et al
    Age and time course of long-term motor and nonmotor complications in Parkinson disease.
    Neurology. 2018 Dec 12. pii: WNL.0000000000006737.
    PubMed     Text format     Abstract available


    Neurosci Lett

  11. GOMEZ G, Saborido MD, Bernardi MA, Gershanik OS, et al
    Regulation of Pleiotrophin and Fyn in the striatum of rats undergoing L-DOPA-induced dyskinesia.
    Neurosci Lett. 2018;666:5-10.
    PubMed     Text format     Abstract available


    PLoS One

  12. HONMA M, Masaoka Y, Koyama S, Kuroda T, et al
    Impaired cognitive modification for estimating time duration in Parkinson's disease.
    PLoS One. 2018;13:e0208956.
    PubMed     Text format     Abstract available

  13. WILLKOMMEN D, Lucio M, Moritz F, Forcisi S, et al
    Metabolomic investigations in cerebrospinal fluid of Parkinson's disease.
    PLoS One. 2018;13:e0208752.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: